The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave ...

The drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its blockbuster drugs Wegovy and ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...

Weight loss jab users have panicked over going cold turkey after pharmacists warned of potential shortages in the UK due to ...

Eli Lilly & Company (NYSE: LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

NPA chairman Olivier Picard said ‘many more people are interested in getting weight loss jabs than would actually be suitable ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Three women arrested when a woman fell seriously ill after using a weight loss jab, allegedly sourced from a North Yorkshire ...